Literature DB >> 12975575

Microtubules, microtubule-interfering agents and apoptosis.

F Mollinedo1, C Gajate.   

Abstract

Microtubules are dynamic polymers that play crucial roles in a large number of cellular functions. Their pivotal role in mitosis makes them a target for the development of anticancer drugs. Microtubule-damaging agents suppress microtubule dynamics, leading to disruption of the mitotic spindle in dividing cells, cell cycle arrest at M phase, and late apoptosis. A better understanding of the processes coupling microtubule damage to the onset of apoptosis will reveal sites of potential intervention in cancer chemotherapy. Inhibition of microtubule dynamics induces persistent modification of biological processes (M arrest) and signaling pathways (mitotic spindle assembly checkpoint activation, Bcl-2 phosphorylation, c-Jun NH(2)-terminal kinase activation), which ultimately lead to apoptosis through the accumulation of signals that finally reach the threshold for the onset of apoptosis or through diminishing the threshold for engagement of cell death. Microtubules serve also as scaffolds for signaling molecules that regulate apoptosis, such as Bim and survivin, and their release from microtubules affect the activities of these apoptosis regulators. Thus, sustained modification of signaling routes and changes in the scaffolding properties of microtubules seem to constitute two major processes in the apoptotic response induced by microtubule-interfering agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975575     DOI: 10.1023/a:1025513106330

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  140 in total

1.  Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.

Authors:  Tiancheng Liu; Lisa Y Wu; Clifford E Berkman
Journal:  Cancer Lett       Date:  2010-05-08       Impact factor: 8.679

2.  Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2011-12-21       Impact factor: 7.446

3.  Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.

Authors:  Giuseppe La Regina; Ruoli Bai; Willeke Rensen; Antonio Coluccia; Francesco Piscitelli; Valerio Gatti; Alessio Bolognesi; Antonio Lavecchia; Ilaria Granata; Amalia Porta; Bruno Maresca; Alessandra Soriani; Maria Luisa Iannitto; Marisa Mariani; Angela Santoni; Andrea Brancale; Cristiano Ferlini; Giulio Dondio; Mario Varasi; Ciro Mercurio; Ernest Hamel; Patrizia Lavia; Ettore Novellino; Romano Silvestri
Journal:  J Med Chem       Date:  2011-11-21       Impact factor: 7.446

4.  MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells.

Authors:  Giampietro Viola; Roberta Bortolozzi; Ernest Hamel; Stefano Moro; Paola Brun; Ignazio Castagliuolo; Maria Grazia Ferlin; Giuseppe Basso
Journal:  Biochem Pharmacol       Date:  2011-09-22       Impact factor: 5.858

5.  Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez Cara; Maria Dora Carrion; Andrea Brancale; Ernest Hamel; Longchuan Chen; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

6.  Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

Authors:  Cheng-Huang Shen; Jia-Jen Shee; Jin-Yi Wu; Yi-Wen Lin; Jiann-Der Wu; Yi-Wen Liu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

7.  Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer.

Authors:  Chew-Wun Wu; Chin-Wen Chi; Tze-Sing Huang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 8.  Targeting microtubules by natural agents for cancer therapy.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

9.  Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane.

Authors:  Olga Azarenko; Tatiana Okouneva; Keith W Singletary; Mary Ann Jordan; Leslie Wilson
Journal:  Carcinogenesis       Date:  2008-10-23       Impact factor: 4.944

10.  Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer.

Authors:  Dannah R Miller; Cherng-Chyi Tzeng; Trey Farmer; Evan T Keller; Steve Caplan; Yu-Shuin Chen; Yeh-Long Chen; Ming-Fong Lin
Journal:  Cancer Lett       Date:  2018-08-03       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.